nodes	percent_of_prediction	percent_of_DWPC	metapath
Carisoprodol—CYP2C19—Gefitinib—lung cancer	0.338	0.508	CbGbCtD
Carisoprodol—CYP2C19—Teniposide—lung cancer	0.328	0.492	CbGbCtD
Carisoprodol—Meprobamate—CYP2E1—lung cancer	0.0112	0.656	CrCbGaD
Carisoprodol—Meprobamate—ABCB1—lung cancer	0.00586	0.344	CrCbGaD
Carisoprodol—Pancytopenia—Pemetrexed—lung cancer	0.00562	0.0184	CcSEcCtD
Carisoprodol—Pancytopenia—Teniposide—lung cancer	0.00455	0.0149	CcSEcCtD
Carisoprodol—Syncope—Crizotinib—lung cancer	0.00404	0.0133	CcSEcCtD
Carisoprodol—Leukopenia—Crizotinib—lung cancer	0.00404	0.0133	CcSEcCtD
Carisoprodol—Hiccups—Irinotecan—lung cancer	0.00399	0.0131	CcSEcCtD
Carisoprodol—Loss of consciousness—Crizotinib—lung cancer	0.00396	0.013	CcSEcCtD
Carisoprodol—Blood disorder—Paclitaxel—lung cancer	0.0039	0.0128	CcSEcCtD
Carisoprodol—Syncope—Pemetrexed—lung cancer	0.0037	0.0121	CcSEcCtD
Carisoprodol—Leukopenia—Pemetrexed—lung cancer	0.00369	0.0121	CcSEcCtD
Carisoprodol—Hiccups—Cisplatin—lung cancer	0.00363	0.0119	CcSEcCtD
Carisoprodol—Loss of consciousness—Pemetrexed—lung cancer	0.00362	0.0119	CcSEcCtD
Carisoprodol—Shock—Crizotinib—lung cancer	0.00362	0.0119	CcSEcCtD
Carisoprodol—Viral infection—Paclitaxel—lung cancer	0.00361	0.0118	CcSEcCtD
Carisoprodol—Flushing—Teniposide—lung cancer	0.00356	0.0117	CcSEcCtD
Carisoprodol—Pancytopenia—Vinblastine—lung cancer	0.00347	0.0114	CcSEcCtD
Carisoprodol—Pancytopenia—Topotecan—lung cancer	0.00337	0.0111	CcSEcCtD
Carisoprodol—Shock—Pemetrexed—lung cancer	0.00331	0.0109	CcSEcCtD
Carisoprodol—Shock—Gefitinib—lung cancer	0.00329	0.0108	CcSEcCtD
Carisoprodol—Dyspepsia—Crizotinib—lung cancer	0.00324	0.0106	CcSEcCtD
Carisoprodol—Agitation—Teniposide—lung cancer	0.00307	0.0101	CcSEcCtD
Carisoprodol—Leukopenia—Teniposide—lung cancer	0.00299	0.00981	CcSEcCtD
Carisoprodol—Dyspepsia—Pemetrexed—lung cancer	0.00296	0.00972	CcSEcCtD
Carisoprodol—Pancytopenia—Vinorelbine—lung cancer	0.00289	0.00947	CcSEcCtD
Carisoprodol—Tachycardia—Teniposide—lung cancer	0.00266	0.00873	CcSEcCtD
Carisoprodol—Orthostatic hypotension—Irinotecan—lung cancer	0.00265	0.00869	CcSEcCtD
Carisoprodol—Irritability—Cisplatin—lung cancer	0.00251	0.00825	CcSEcCtD
Carisoprodol—Dizziness—Crizotinib—lung cancer	0.00243	0.00799	CcSEcCtD
Carisoprodol—Orthostatic hypotension—Cisplatin—lung cancer	0.0024	0.00789	CcSEcCtD
Carisoprodol—Back pain—Topotecan—lung cancer	0.00239	0.00786	CcSEcCtD
Carisoprodol—Back pain—Erlotinib—lung cancer	0.00237	0.00778	CcSEcCtD
Carisoprodol—Vomiting—Crizotinib—lung cancer	0.00234	0.00768	CcSEcCtD
Carisoprodol—Pancytopenia—Gemcitabine—lung cancer	0.00232	0.00761	CcSEcCtD
Carisoprodol—Vertigo—Vinblastine—lung cancer	0.00229	0.00751	CcSEcCtD
Carisoprodol—Leukopenia—Vinblastine—lung cancer	0.00228	0.00749	CcSEcCtD
Carisoprodol—Flushing—Vinorelbine—lung cancer	0.00226	0.00741	CcSEcCtD
Carisoprodol—Dizziness—Pemetrexed—lung cancer	0.00222	0.0073	CcSEcCtD
Carisoprodol—Ataxia—Paclitaxel—lung cancer	0.00222	0.0073	CcSEcCtD
Carisoprodol—Leukopenia—Topotecan—lung cancer	0.00222	0.00727	CcSEcCtD
Carisoprodol—Convulsion—Vinblastine—lung cancer	0.00221	0.00725	CcSEcCtD
Carisoprodol—Syncope—Erlotinib—lung cancer	0.0022	0.00721	CcSEcCtD
Carisoprodol—Nausea—Crizotinib—lung cancer	0.00219	0.00718	CcSEcCtD
Carisoprodol—Pancytopenia—Cisplatin—lung cancer	0.00216	0.00709	CcSEcCtD
Carisoprodol—Orthostatic hypotension—Paclitaxel—lung cancer	0.00216	0.00709	CcSEcCtD
Carisoprodol—Loss of consciousness—Erlotinib—lung cancer	0.00215	0.00707	CcSEcCtD
Carisoprodol—Vomiting—Pemetrexed—lung cancer	0.00214	0.00702	CcSEcCtD
Carisoprodol—Vomiting—Gefitinib—lung cancer	0.00213	0.00698	CcSEcCtD
Carisoprodol—Blood disorder—Doxorubicin—lung cancer	0.00206	0.00677	CcSEcCtD
Carisoprodol—Back pain—Vinorelbine—lung cancer	0.00205	0.00672	CcSEcCtD
Carisoprodol—Nausea—Pemetrexed—lung cancer	0.002	0.00656	CcSEcCtD
Carisoprodol—Nausea—Gefitinib—lung cancer	0.00199	0.00652	CcSEcCtD
Carisoprodol—Pancytopenia—Etoposide—lung cancer	0.00198	0.0065	CcSEcCtD
Carisoprodol—Shock—Erlotinib—lung cancer	0.00197	0.00646	CcSEcCtD
Carisoprodol—Pancytopenia—Paclitaxel—lung cancer	0.00194	0.00637	CcSEcCtD
Carisoprodol—Viral infection—Doxorubicin—lung cancer	0.00191	0.00626	CcSEcCtD
Carisoprodol—Vertigo—Vinorelbine—lung cancer	0.0019	0.00624	CcSEcCtD
Carisoprodol—Leukopenia—Vinorelbine—lung cancer	0.00189	0.00622	CcSEcCtD
Carisoprodol—Ataxia—Docetaxel—lung cancer	0.00188	0.00619	CcSEcCtD
Carisoprodol—Flushing—Irinotecan—lung cancer	0.00186	0.00611	CcSEcCtD
Carisoprodol—Orthostatic hypotension—Docetaxel—lung cancer	0.00183	0.00601	CcSEcCtD
Carisoprodol—Insomnia—Erlotinib—lung cancer	0.00181	0.00593	CcSEcCtD
Carisoprodol—Dyspepsia—Topotecan—lung cancer	0.00178	0.00584	CcSEcCtD
Carisoprodol—Dyspepsia—Erlotinib—lung cancer	0.00176	0.00578	CcSEcCtD
Carisoprodol—Vomiting—Teniposide—lung cancer	0.00173	0.00569	CcSEcCtD
Carisoprodol—Hiccups—Doxorubicin—lung cancer	0.00172	0.00566	CcSEcCtD
Carisoprodol—Headache—Teniposide—lung cancer	0.00171	0.0056	CcSEcCtD
Carisoprodol—Flushing—Cisplatin—lung cancer	0.00169	0.00555	CcSEcCtD
Carisoprodol—Back pain—Irinotecan—lung cancer	0.00169	0.00555	CcSEcCtD
Carisoprodol—Tachycardia—Vinorelbine—lung cancer	0.00169	0.00554	CcSEcCtD
Carisoprodol—Back pain—Gemcitabine—lung cancer	0.00164	0.0054	CcSEcCtD
Carisoprodol—Pancytopenia—Docetaxel—lung cancer	0.00164	0.0054	CcSEcCtD
Carisoprodol—Nausea—Teniposide—lung cancer	0.00162	0.00531	CcSEcCtD
Carisoprodol—Vertigo—Irinotecan—lung cancer	0.00157	0.00515	CcSEcCtD
Carisoprodol—Syncope—Irinotecan—lung cancer	0.00157	0.00514	CcSEcCtD
Carisoprodol—Leukopenia—Irinotecan—lung cancer	0.00156	0.00513	CcSEcCtD
Carisoprodol—Flushing—Etoposide—lung cancer	0.00155	0.00508	CcSEcCtD
Carisoprodol—Loss of consciousness—Irinotecan—lung cancer	0.00153	0.00504	CcSEcCtD
Carisoprodol—Leukopenia—Gemcitabine—lung cancer	0.00152	0.005	CcSEcCtD
Carisoprodol—Flushing—Paclitaxel—lung cancer	0.00152	0.00498	CcSEcCtD
Carisoprodol—Tremor—Cisplatin—lung cancer	0.00149	0.00488	CcSEcCtD
Carisoprodol—Leukopenia—Cisplatin—lung cancer	0.00142	0.00466	CcSEcCtD
Carisoprodol—Back pain—Etoposide—lung cancer	0.0014	0.00461	CcSEcCtD
Carisoprodol—Shock—Irinotecan—lung cancer	0.0014	0.0046	CcSEcCtD
Carisoprodol—Irritability—Methotrexate—lung cancer	0.00138	0.00453	CcSEcCtD
Carisoprodol—Back pain—Paclitaxel—lung cancer	0.00138	0.00452	CcSEcCtD
Carisoprodol—Dizziness—Vinblastine—lung cancer	0.00137	0.00451	CcSEcCtD
Carisoprodol—Convulsion—Cisplatin—lung cancer	0.00137	0.00451	CcSEcCtD
Carisoprodol—Ataxia—Methotrexate—lung cancer	0.00136	0.00446	CcSEcCtD
Carisoprodol—Dizziness—Topotecan—lung cancer	0.00134	0.00439	CcSEcCtD
Carisoprodol—Tremor—Paclitaxel—lung cancer	0.00133	0.00438	CcSEcCtD
Carisoprodol—Vomiting—Vinblastine—lung cancer	0.00132	0.00434	CcSEcCtD
Carisoprodol—Dizziness—Erlotinib—lung cancer	0.00132	0.00434	CcSEcCtD
Carisoprodol—Agitation—Paclitaxel—lung cancer	0.00131	0.0043	CcSEcCtD
Carisoprodol—Vertigo—Etoposide—lung cancer	0.0013	0.00428	CcSEcCtD
Carisoprodol—Headache—Vinblastine—lung cancer	0.0013	0.00428	CcSEcCtD
Carisoprodol—Leukopenia—Etoposide—lung cancer	0.0013	0.00427	CcSEcCtD
Carisoprodol—Insomnia—Irinotecan—lung cancer	0.00129	0.00423	CcSEcCtD
Carisoprodol—Flushing—Docetaxel—lung cancer	0.00129	0.00422	CcSEcCtD
Carisoprodol—Vomiting—Topotecan—lung cancer	0.00128	0.00422	CcSEcCtD
Carisoprodol—Vertigo—Paclitaxel—lung cancer	0.00128	0.0042	CcSEcCtD
Carisoprodol—Syncope—Paclitaxel—lung cancer	0.00128	0.00419	CcSEcCtD
Carisoprodol—Loss of consciousness—Etoposide—lung cancer	0.00128	0.00419	CcSEcCtD
Carisoprodol—Leukopenia—Paclitaxel—lung cancer	0.00127	0.00418	CcSEcCtD
Carisoprodol—Vomiting—Erlotinib—lung cancer	0.00127	0.00417	CcSEcCtD
Carisoprodol—Somnolence—Irinotecan—lung cancer	0.00127	0.00416	CcSEcCtD
Carisoprodol—Headache—Topotecan—lung cancer	0.00127	0.00415	CcSEcCtD
Carisoprodol—Tachycardia—Cisplatin—lung cancer	0.00126	0.00415	CcSEcCtD
Carisoprodol—Convulsion—Etoposide—lung cancer	0.00126	0.00413	CcSEcCtD
Carisoprodol—Insomnia—Gemcitabine—lung cancer	0.00126	0.00412	CcSEcCtD
Carisoprodol—Dyspepsia—Irinotecan—lung cancer	0.00125	0.00412	CcSEcCtD
Carisoprodol—Headache—Erlotinib—lung cancer	0.00125	0.00411	CcSEcCtD
Carisoprodol—Loss of consciousness—Paclitaxel—lung cancer	0.00125	0.00411	CcSEcCtD
Carisoprodol—Nausea—Vinblastine—lung cancer	0.00123	0.00405	CcSEcCtD
Carisoprodol—Somnolence—Gemcitabine—lung cancer	0.00123	0.00405	CcSEcCtD
Carisoprodol—Convulsion—Paclitaxel—lung cancer	0.00123	0.00405	CcSEcCtD
Carisoprodol—Nausea—Topotecan—lung cancer	0.0012	0.00394	CcSEcCtD
Carisoprodol—Nausea—Erlotinib—lung cancer	0.00119	0.0039	CcSEcCtD
Carisoprodol—Pancytopenia—Methotrexate—lung cancer	0.00119	0.00389	CcSEcCtD
Carisoprodol—Ataxia—Doxorubicin—lung cancer	0.00118	0.00386	CcSEcCtD
Carisoprodol—Back pain—Docetaxel—lung cancer	0.00117	0.00383	CcSEcCtD
Carisoprodol—Tachycardia—Etoposide—lung cancer	0.00116	0.0038	CcSEcCtD
Carisoprodol—Shock—Paclitaxel—lung cancer	0.00114	0.00375	CcSEcCtD
Carisoprodol—Dizziness—Vinorelbine—lung cancer	0.00114	0.00375	CcSEcCtD
Carisoprodol—Orthostatic hypotension—Doxorubicin—lung cancer	0.00114	0.00375	CcSEcCtD
Carisoprodol—Tachycardia—Paclitaxel—lung cancer	0.00113	0.00372	CcSEcCtD
Carisoprodol—Drowsiness—Methotrexate—lung cancer	0.00111	0.00365	CcSEcCtD
Carisoprodol—Vomiting—Vinorelbine—lung cancer	0.0011	0.00361	CcSEcCtD
Carisoprodol—Headache—Vinorelbine—lung cancer	0.00108	0.00355	CcSEcCtD
Carisoprodol—Syncope—Docetaxel—lung cancer	0.00108	0.00355	CcSEcCtD
Carisoprodol—Leukopenia—Docetaxel—lung cancer	0.00108	0.00355	CcSEcCtD
Carisoprodol—Loss of consciousness—Docetaxel—lung cancer	0.00106	0.00348	CcSEcCtD
Carisoprodol—Somnolence—Etoposide—lung cancer	0.00105	0.00346	CcSEcCtD
Carisoprodol—Insomnia—Paclitaxel—lung cancer	0.00105	0.00345	CcSEcCtD
Carisoprodol—Convulsion—Docetaxel—lung cancer	0.00105	0.00343	CcSEcCtD
Carisoprodol—Somnolence—Paclitaxel—lung cancer	0.00103	0.00339	CcSEcCtD
Carisoprodol—Pancytopenia—Doxorubicin—lung cancer	0.00103	0.00337	CcSEcCtD
Carisoprodol—Nausea—Vinorelbine—lung cancer	0.00103	0.00337	CcSEcCtD
Carisoprodol—Dyspepsia—Paclitaxel—lung cancer	0.00102	0.00336	CcSEcCtD
Carisoprodol—Shock—Docetaxel—lung cancer	0.000969	0.00318	CcSEcCtD
Carisoprodol—CYP2C19—CYP2E1 reactions—CYP2A7—lung cancer	0.000966	0.0819	CbGpPWpGaD
Carisoprodol—Drowsiness—Doxorubicin—lung cancer	0.000964	0.00316	CcSEcCtD
Carisoprodol—Tachycardia—Docetaxel—lung cancer	0.000961	0.00316	CcSEcCtD
Carisoprodol—Dizziness—Irinotecan—lung cancer	0.000942	0.00309	CcSEcCtD
Carisoprodol—Vomiting—Irinotecan—lung cancer	0.000906	0.00297	CcSEcCtD
Carisoprodol—Headache—Irinotecan—lung cancer	0.000893	0.00293	CcSEcCtD
Carisoprodol—Insomnia—Docetaxel—lung cancer	0.000891	0.00293	CcSEcCtD
Carisoprodol—Vomiting—Gemcitabine—lung cancer	0.000882	0.0029	CcSEcCtD
Carisoprodol—Somnolence—Docetaxel—lung cancer	0.000876	0.00288	CcSEcCtD
Carisoprodol—Headache—Gemcitabine—lung cancer	0.000869	0.00286	CcSEcCtD
Carisoprodol—Dyspepsia—Docetaxel—lung cancer	0.000867	0.00285	CcSEcCtD
Carisoprodol—Nausea—Irinotecan—lung cancer	0.000846	0.00278	CcSEcCtD
Carisoprodol—Back pain—Methotrexate—lung cancer	0.000841	0.00276	CcSEcCtD
Carisoprodol—Nausea—Gemcitabine—lung cancer	0.000824	0.00271	CcSEcCtD
Carisoprodol—Vomiting—Cisplatin—lung cancer	0.000823	0.0027	CcSEcCtD
Carisoprodol—Flushing—Doxorubicin—lung cancer	0.000803	0.00264	CcSEcCtD
Carisoprodol—Dizziness—Etoposide—lung cancer	0.000784	0.00257	CcSEcCtD
Carisoprodol—Vertigo—Methotrexate—lung cancer	0.000781	0.00257	CcSEcCtD
Carisoprodol—Leukopenia—Methotrexate—lung cancer	0.000779	0.00256	CcSEcCtD
Carisoprodol—Dizziness—Paclitaxel—lung cancer	0.000768	0.00252	CcSEcCtD
Carisoprodol—Nausea—Cisplatin—lung cancer	0.000768	0.00252	CcSEcCtD
Carisoprodol—Convulsion—Methotrexate—lung cancer	0.000754	0.00247	CcSEcCtD
Carisoprodol—Vomiting—Etoposide—lung cancer	0.000754	0.00247	CcSEcCtD
Carisoprodol—Headache—Etoposide—lung cancer	0.000742	0.00244	CcSEcCtD
Carisoprodol—Vomiting—Paclitaxel—lung cancer	0.000739	0.00243	CcSEcCtD
Carisoprodol—Back pain—Doxorubicin—lung cancer	0.000729	0.00239	CcSEcCtD
Carisoprodol—Headache—Paclitaxel—lung cancer	0.000728	0.00239	CcSEcCtD
Carisoprodol—Nausea—Etoposide—lung cancer	0.000704	0.00231	CcSEcCtD
Carisoprodol—Agitation—Doxorubicin—lung cancer	0.000692	0.00227	CcSEcCtD
Carisoprodol—Nausea—Paclitaxel—lung cancer	0.00069	0.00227	CcSEcCtD
Carisoprodol—Vertigo—Doxorubicin—lung cancer	0.000677	0.00222	CcSEcCtD
Carisoprodol—Syncope—Doxorubicin—lung cancer	0.000675	0.00222	CcSEcCtD
Carisoprodol—Leukopenia—Doxorubicin—lung cancer	0.000674	0.00221	CcSEcCtD
Carisoprodol—Loss of consciousness—Doxorubicin—lung cancer	0.000662	0.00217	CcSEcCtD
Carisoprodol—Convulsion—Doxorubicin—lung cancer	0.000653	0.00214	CcSEcCtD
Carisoprodol—Dizziness—Docetaxel—lung cancer	0.000651	0.00214	CcSEcCtD
Carisoprodol—Insomnia—Methotrexate—lung cancer	0.000642	0.00211	CcSEcCtD
Carisoprodol—Somnolence—Methotrexate—lung cancer	0.000631	0.00207	CcSEcCtD
Carisoprodol—Vomiting—Docetaxel—lung cancer	0.000626	0.00206	CcSEcCtD
Carisoprodol—Dyspepsia—Methotrexate—lung cancer	0.000625	0.00205	CcSEcCtD
Carisoprodol—Headache—Docetaxel—lung cancer	0.000617	0.00203	CcSEcCtD
Carisoprodol—Shock—Doxorubicin—lung cancer	0.000605	0.00199	CcSEcCtD
Carisoprodol—Tachycardia—Doxorubicin—lung cancer	0.0006	0.00197	CcSEcCtD
Carisoprodol—CYP2C19—Xenobiotics—CYP2A7—lung cancer	0.000599	0.0508	CbGpPWpGaD
Carisoprodol—Nausea—Docetaxel—lung cancer	0.000585	0.00192	CcSEcCtD
Carisoprodol—CYP2C19—CYP2E1 reactions—CYP2A6—lung cancer	0.000561	0.0476	CbGpPWpGaD
Carisoprodol—Insomnia—Doxorubicin—lung cancer	0.000556	0.00183	CcSEcCtD
Carisoprodol—Somnolence—Doxorubicin—lung cancer	0.000546	0.00179	CcSEcCtD
Carisoprodol—Dyspepsia—Doxorubicin—lung cancer	0.000541	0.00178	CcSEcCtD
Carisoprodol—CYP2C19—CYP2E1 reactions—CYP2E1—lung cancer	0.000477	0.0405	CbGpPWpGaD
Carisoprodol—Dizziness—Methotrexate—lung cancer	0.000469	0.00154	CcSEcCtD
Carisoprodol—Vomiting—Methotrexate—lung cancer	0.000451	0.00148	CcSEcCtD
Carisoprodol—Headache—Methotrexate—lung cancer	0.000445	0.00146	CcSEcCtD
Carisoprodol—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—lung cancer	0.000442	0.0375	CbGpPWpGaD
Carisoprodol—Nausea—Methotrexate—lung cancer	0.000422	0.00138	CcSEcCtD
Carisoprodol—Dizziness—Doxorubicin—lung cancer	0.000406	0.00133	CcSEcCtD
Carisoprodol—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—lung cancer	0.000402	0.0341	CbGpPWpGaD
Carisoprodol—Vomiting—Doxorubicin—lung cancer	0.000391	0.00128	CcSEcCtD
Carisoprodol—Headache—Doxorubicin—lung cancer	0.000385	0.00126	CcSEcCtD
Carisoprodol—Nausea—Doxorubicin—lung cancer	0.000365	0.0012	CcSEcCtD
Carisoprodol—CYP2C19—Xenobiotics—CYP2A6—lung cancer	0.000348	0.0295	CbGpPWpGaD
Carisoprodol—CYP2C19—Tamoxifen metabolism—CYP2A6—lung cancer	0.000334	0.0284	CbGpPWpGaD
Carisoprodol—CYP2C19—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	0.000327	0.0277	CbGpPWpGaD
Carisoprodol—CYP2C19—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	0.000312	0.0264	CbGpPWpGaD
Carisoprodol—CYP2C19—Xenobiotics—CYP2E1—lung cancer	0.000296	0.0251	CbGpPWpGaD
Carisoprodol—CYP2C19—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	0.000293	0.0248	CbGpPWpGaD
Carisoprodol—CYP2C19—Tamoxifen metabolism—CYP2E1—lung cancer	0.000284	0.0241	CbGpPWpGaD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.000249	0.0211	CbGpPWpGaD
Carisoprodol—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.000245	0.0208	CbGpPWpGaD
Carisoprodol—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000239	0.0203	CbGpPWpGaD
Carisoprodol—CYP2C19—Xenobiotics—CYP1A1—lung cancer	0.000212	0.018	CbGpPWpGaD
Carisoprodol—CYP2C19—Tamoxifen metabolism—CYP1A1—lung cancer	0.000204	0.0173	CbGpPWpGaD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000202	0.0171	CbGpPWpGaD
Carisoprodol—CYP2C19—Arachidonic acid metabolism—HPGDS—lung cancer	0.000174	0.0148	CbGpPWpGaD
Carisoprodol—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	0.000159	0.0134	CbGpPWpGaD
Carisoprodol—CYP2C19—Melatonin metabolism and effects—CYP1A1—lung cancer	0.000158	0.0134	CbGpPWpGaD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.000144	0.0123	CbGpPWpGaD
Carisoprodol—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000143	0.0121	CbGpPWpGaD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000123	0.0104	CbGpPWpGaD
Carisoprodol—CYP2C19—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000121	0.0103	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—CNDP2—lung cancer	0.000118	0.01	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTM2—lung cancer	0.000118	0.01	CbGpPWpGaD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000117	0.00993	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—GSTM2—lung cancer	0.000117	0.0099	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—CYP2A7—lung cancer	0.000107	0.00908	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—CYP2A7—lung cancer	0.000106	0.00896	CbGpPWpGaD
Carisoprodol—CYP2C19—Arachidonic acid metabolism—CYP1A1—lung cancer	0.000102	0.00866	CbGpPWpGaD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	9.95e-05	0.00844	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTA3—lung cancer	9.54e-05	0.0081	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—GSTA3—lung cancer	9.41e-05	0.00798	CbGpPWpGaD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	8.82e-05	0.00748	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTA4—lung cancer	8.73e-05	0.0074	CbGpPWpGaD
Carisoprodol—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—lung cancer	8.71e-05	0.00739	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—GSTA4—lung cancer	8.61e-05	0.0073	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTA2—lung cancer	8.51e-05	0.00722	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTA1—lung cancer	8.21e-05	0.00696	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—AKR1C1—lung cancer	7.75e-05	0.00657	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—UGT1A1—lung cancer	7.63e-05	0.00647	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—UGT1A1—lung cancer	7.52e-05	0.00638	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	7.5e-05	0.00637	CbGpPWpGaD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	7.15e-05	0.00607	CbGpPWpGaD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	6.58e-05	0.00558	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—HPGDS—lung cancer	6.49e-05	0.0055	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTT1—lung cancer	6.29e-05	0.00534	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GCLC—lung cancer	6.22e-05	0.00528	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—CYP2A6—lung cancer	6.22e-05	0.00528	CbGpPWpGaD
Carisoprodol—CYP2C19—Arachidonic acid metabolism—PTGS2—lung cancer	6.07e-05	0.00515	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	5.69e-05	0.00482	CbGpPWpGaD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—POMC—lung cancer	5.33e-05	0.00452	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—CYP2E1—lung cancer	5.29e-05	0.00449	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—CYP2E1—lung cancer	5.22e-05	0.00442	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	4.42e-05	0.00375	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTP1—lung cancer	4.36e-05	0.0037	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—GSTP1—lung cancer	4.3e-05	0.00365	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTM1—lung cancer	4.01e-05	0.0034	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—GSTM1—lung cancer	3.95e-05	0.00335	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—CYP1A1—lung cancer	3.8e-05	0.00322	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—CYP1A1—lung cancer	3.75e-05	0.00318	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—AZIN2—lung cancer	3.34e-05	0.00283	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—COL4A3BP—lung cancer	3.34e-05	0.00283	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	3.12e-05	0.00264	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	3.02e-05	0.00256	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ATP5H—lung cancer	2.84e-05	0.00241	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—POMC—lung cancer	2.83e-05	0.0024	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	2.61e-05	0.00221	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PLBD1—lung cancer	2.53e-05	0.00215	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	2.49e-05	0.00211	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—HSD17B10—lung cancer	2.32e-05	0.00196	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CKB—lung cancer	2.15e-05	0.00183	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CNDP2—lung cancer	2.02e-05	0.00172	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTM2—lung cancer	2.02e-05	0.00172	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—MTMR3—lung cancer	1.97e-05	0.00167	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PGAM1—lung cancer	1.92e-05	0.00163	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP2A7—lung cancer	1.83e-05	0.00155	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—SDC4—lung cancer	1.79e-05	0.00152	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTA3—lung cancer	1.63e-05	0.00138	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—RRM1—lung cancer	1.63e-05	0.00138	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—B4GALT5—lung cancer	1.53e-05	0.0013	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTA4—lung cancer	1.49e-05	0.00127	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.46e-05	0.00124	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTA2—lung cancer	1.45e-05	0.00123	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTA1—lung cancer	1.4e-05	0.00119	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ABCC3—lung cancer	1.39e-05	0.00118	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—AKR1C1—lung cancer	1.34e-05	0.00114	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—UGT1A1—lung cancer	1.3e-05	0.00111	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GNG11—lung cancer	1.26e-05	0.00107	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.25e-05	0.00106	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ALDOA—lung cancer	1.2e-05	0.00102	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—NCOA3—lung cancer	1.16e-05	0.000986	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.14e-05	0.000969	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ADCY1—lung cancer	1.13e-05	0.00096	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ABCG2—lung cancer	1.13e-05	0.00096	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—HPGDS—lung cancer	1.11e-05	0.000941	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ENO2—lung cancer	1.11e-05	0.000941	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PPP2R1B—lung cancer	1.1e-05	0.000935	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.09e-05	0.000923	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTT1—lung cancer	1.08e-05	0.000913	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GCLC—lung cancer	1.06e-05	0.000902	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP2A6—lung cancer	1.06e-05	0.000902	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.06e-05	0.000899	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ENO1—lung cancer	1.01e-05	0.000855	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1e-05	0.000852	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	9.92e-06	0.000841	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP2E1—lung cancer	9.04e-06	0.000767	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—NQO1—lung cancer	8.94e-06	0.000759	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	8.76e-06	0.000743	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	8.68e-06	0.000736	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—STK11—lung cancer	8.06e-06	0.000684	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	7.57e-06	0.000642	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTP1—lung cancer	7.46e-06	0.000633	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CAT—lung cancer	7.26e-06	0.000616	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.22e-06	0.000612	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ABCB1—lung cancer	7.06e-06	0.000599	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—TYMS—lung cancer	6.93e-06	0.000588	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTM1—lung cancer	6.85e-06	0.000581	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP1A1—lung cancer	6.5e-06	0.000551	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ERCC2—lung cancer	6.44e-06	0.000547	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—APOA1—lung cancer	5.57e-06	0.000473	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.34e-06	0.000453	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PIK3CG—lung cancer	5.09e-06	0.000432	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—POMC—lung cancer	4.84e-06	0.000411	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CREBBP—lung cancer	4.72e-06	0.0004	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PIK3CD—lung cancer	4.47e-06	0.000379	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ALB—lung cancer	4.42e-06	0.000375	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PIK3CB—lung cancer	3.9e-06	0.000331	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PTGS2—lung cancer	3.86e-06	0.000328	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PTEN—lung cancer	3.37e-06	0.000286	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—EP300—lung cancer	3.21e-06	0.000273	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PIK3CA—lung cancer	2.38e-06	0.000202	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—AKT1—lung cancer	1.94e-06	0.000165	CbGpPWpGaD
